Biofrontera Inc. (BFRI)Healthcare | Drug Manufacturers - Specialty & Generic | Woburn, United States | NasdaqCM
1.07 USD
-0.02
(-1.835%) ⇩
(April 21, 2026, 12:24 p.m.
EDT)
Short-term: ★★★★★ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 11:30 p.m. EDT
A high-conviction short-term bullish reversal is evidenced by the price breaking above the 50-day moving average, strong momentum over the last two weeks, and positive news sentiment. However, the long-term outlook remains poor due to negative earnings, a negative adjusted forward predicted direction, and a lack of analyst support despite optimistic headlines. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.104957 |
| AutoARIMA | 0.114335 |
| AutoETS | 0.116971 |
| MSTL | 0.120747 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 80% |
| H-stat | 0.78 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.132 |
| Excess Kurtosis | -0.18 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 58.788 |
| Revenue per Share | 4.1 |
| Market Cap | 12,463,706 |
| Forward P/E | -4.65 |
| Beta | 0.64 |
| Profit Margins | -25.26% |
| Website | https://www.biofrontera-us.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 0.30538917 |
| Address1 | 660 Main Street |
| Address2 | 1st Floor |
| All Time High | 292.6 |
| All Time Low | 0.536 |
| Ask | 1.34 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 119,800 |
| Average Daily Volume3 Month | 373,414 |
| Average Volume | 373,414 |
| Average Volume10Days | 119,800 |
| Beta | 0.644 |
| Bid | 0.792 |
| Bid Size | 2 |
| Book Value | 0.9 |
| City | Woburn |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.07 |
| Current Ratio | 1.52 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 1.1 |
| Day Low | 1.03 |
| Debt To Equity | 58.788 |
| Display Name | Biofrontera |
| Earnings Call Timestamp End | 1,773,928,800 |
| Earnings Call Timestamp Start | 1,773,928,800 |
| Earnings Timestamp | 1,773,923,400 |
| Earnings Timestamp End | 1,778,761,800 |
| Earnings Timestamp Start | 1,778,761,800 |
| Ebitda | -11,210,000 |
| Ebitda Margins | -0.26879 |
| Enterprise To Ebitda | -1.111 |
| Enterprise To Revenue | 0.299 |
| Enterprise Value | 12,456,672 |
| Eps Current Year | -0.06 |
| Eps Forward | -0.23 |
| Eps Trailing Twelve Months | -1.04 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.89698 |
| Fifty Day Average Change | 0.17302006 |
| Fifty Day Average Change Percent | 0.19289178 |
| Fifty Two Week Change Percent | 30.538918 |
| Fifty Two Week High | 1.19 |
| Fifty Two Week High Change | -0.120000005 |
| Fifty Two Week High Change Percent | -0.10084034 |
| Fifty Two Week Low | 0.536 |
| Fifty Two Week Low Change | 0.53400004 |
| Fifty Two Week Low Change Percent | 0.9962687 |
| Fifty Two Week Range | 0.536 - 1.19 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,635,514,200,000 |
| Float Shares | 7,948,233 |
| Forward Eps | -0.23 |
| Forward P E | -4.652174 |
| Free Cashflow | -2,362,000 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 84 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.73710996 |
| Gross Profits | 30,741,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.14115 |
| Held Percent Institutions | 0.23684 |
| Implied Shares Outstanding | 11,648,323 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Industry Disp | Drug Manufacturers - Specialty & Generic |
| Industry Key | drug-manufacturers-specialty-generic |
| Ipo Expected Date | 2,021-10-29 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,688,515,200 |
| Last Split Factor | 1:20 |
| Long Business Summary | Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts. |
| Long Name | Biofrontera Inc. |
| Market | us_market |
| Market Cap | 12,463,706 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_531568773 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -10,536,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 12,638,430 |
| Number Of Analyst Opinions | 2 |
| Open | 1.1 |
| Operating Cashflow | -13,361,000 |
| Operating Margins | 0.26661 |
| Payout Ratio | 0.0 |
| Phone | 781 245 1325 |
| Previous Close | 1.09 |
| Price Eps Current Year | -17.833334 |
| Price Hint | 4 |
| Price To Book | 1.188889 |
| Price To Sales Trailing12 Months | 0.298854 |
| Profit Margins | -0.25263 |
| Quick Ratio | 1.311 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.01999998 |
| Regular Market Change Percent | -1.8348606 |
| Regular Market Day High | 1.1 |
| Regular Market Day Low | 1.03 |
| Regular Market Day Range | 1.03 - 1.1 |
| Regular Market Open | 1.1 |
| Regular Market Previous Close | 1.09 |
| Regular Market Price | 1.07 |
| Regular Market Time | 1,776,788,664 |
| Regular Market Volume | 67,396 |
| Return On Assets | -0.27998 |
| Return On Equity | -1.413 |
| Revenue Growth | 0.362 |
| Revenue Per Share | 4.1 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 11,648,323 |
| Shares Percent Shares Out | 0.0254 |
| Shares Short | 295,934 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 150,744 |
| Short Name | Biofrontera Inc. |
| Short Percent Of Float | 0.025899999 |
| Short Ratio | 2.53 |
| Source Interval | 15 |
| State | MA |
| Symbol | BFRI |
| Target High Price | 9.0 |
| Target Low Price | 3.0 |
| Target Mean Price | 6.0 |
| Target Median Price | 6.0 |
| Total Cash | 6,401,000 |
| Total Cash Per Share | 0.55 |
| Total Debt | 6,161,000 |
| Total Revenue | 41,705,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.04 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.901265 |
| Two Hundred Day Average Change | 0.16873503 |
| Two Hundred Day Average Change Percent | 0.18722022 |
| Type Disp | Equity |
| Volume | 67,396 |
| Website | https://www.biofrontera-us.com |
| Zip | 1,801 |